Research on improving outcomes for lung transplant donors and recipients
Official title: Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes: PROMISE-Lung Study
Run by Duke University · NCT06399302 · Data updated 2026-11-12
This study is trying to see how different donor and medical practices affect the health of lung transplant patients and donors, while also looking for blood markers that might predict complications after the surgery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2600 (estimated) |
| Sponsor | Duke University Academic / other |
| Locations | 19 sites (Los Angeles, California and 18 other locations) |
| Status | Recruiting |
| Started | September 3, 2024 |
| Main results expected | June 30, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | August 7, 2026 |
| Trial ID | NCT06399302 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older who are listed for or have recently undergone a lung transplant.
✕Probably not a fit
Patients who are unwilling to provide informed consent or have significant medical issues that may complicate participation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to gather extensive clinical data, blood samples, and patient-reported outcomes from 2,600 lung transplant candidates, donors, and recipients across multiple centers. The research will focus on understanding how variations in donor and medical practices affect clinical outcomes and will identify serum biomarkers that predict post-transplant complications. Participants will be recruited either before their lung transplant or within 30 days after the procedure, with data collected during standard care visits to minimize additional burdens on participants. The study is designed to create a valuable resource for future research in lung transplantation.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies and better outcomes for lung transplant patients.
How similar studies have gone: Other studies have shown success in using similar observational approaches to improve transplant outcomes, indicating that this methodology is both tested and promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Able to understand and provide informed consent 2. ≥ 18 years of age at the time of written informed consent 3. Anticipated listing or listed for a single or bilateral cadaveric donor lung transplant or having received a lung transplant within 30 days * Participants undergoing repeat lung transplantation or multi-organ transplantation are eligible if they meet the inclusion/exclusion criteria. Exclusion Criteria: 1. Unwillingness of a participant or legally authorized representative (LAR) to give written informed consent or comply with study protocol 2. Pregnancy or plans to become pregnant 3. Past or current medical problems or findings from physical examination or laboratory testing, which, in the opinion of the investigator, may pose additional risks from participation in the study, may interfere with the participant's ability to comply with study requirements or that may impact the quality or interpretation of the data obtained from the study.
Where it's running
-
University of California Los Angeles
Los Angeles, California, United States Recruiting -
University of California at San Francisco
San Francisco, California, United States Recruiting -
Stanford University Medical Center
Stanford, California, United States Recruiting -
University of Miami
Miami, Florida, United States Recruiting -
Johns Hopkins University
Baltimore, Maryland, United States Recruiting -
Brigham and Womens Hospital
Boston, Massachusetts, United States Recruiting
Show 13 more locations
-
University of Michigan
Ann Arbor, Michigan, United States Recruiting -
University of Minnesota
Minneapolis, Minnesota, United States Recruiting -
New York University
New York, New York, United States Recruiting -
Columbia University
New York, New York, United States Recruiting -
Duke University Medical Center
Durham, North Carolina, United States Recruiting -
University of Pennsylvania
Philadelphia, Pennsylvania, United States Recruiting -
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States Recruiting -
Vanderbilt University Medical Center
Nashville, Tennessee, United States Recruiting -
Houston Methodist Hospital, Texas Medical Center
Houston, Texas, United States Recruiting -
Inova Fairfax Hospital
Falls Church, Virginia, United States Recruiting -
University of Washington
Seattle, Washington, United States Recruiting -
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States Recruiting -
University Health Network
Toronto, Canada, Canada Recruiting
Study contacts
- Principal investigator: Scott M Palmer, MD, MHS — Duke University School of Medicine, Department of Medicine
- Study coordinator: Allyn Damman
- Email: allyn.damman@duke.edu
- Phone: 919-259-4414
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Identifying biomarkers for lung transplant dysfunction
This study is trying to find specific markers in the body that can help doctors understand and manage problems after lung transplants for patients at Foch Hospital.
-
Cytokine filtration in lung transplantation
This study is testing whether using a special device to filter out harmful substances during lung transplants can help patients have fewer complications and live longer.
-
Multidisciplinary non-drug program to improve quality of life after solid organ transplant
A multidisciplinary, non-drug program using acupuncture, remote physical rehab, and brain-health activities is being tested to see if it can improve quality of life for adults at least one year after heart, kidney, liver, or lung transplant.
-
Multimodal prospective approach to understand acute and chronic lung transplant rejection
This project will see if blood tests, airway sampling, imaging, and genetic analyses can identify which adults who have had or are being evaluated for a lung transplant will develop antibody‑mediated rejection and later chronic graft dysfunction.
-
Hyperpolarized xenon-129 MRI signatures to detect and manage acute cellular rejection after lung transplant
We will see if hyperpolarized xenon-129 MRI can detect early acute cellular rejection in recent lung transplant recipients and guide targeted bronchoscopic sampling.
-
Airway response to exercise after double lung transplant
This study will see if short (5-minute) versus longer (15-minute) constant-work exercise causes different airway narrowing and breathlessness in people who have had a double lung transplant.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.